“Not Applicable”
“Not Applicable”
“Not Applicable”
This invention relates generally to container capping systems and more particularly to systems for capping pharmaceutical vials to provide ready access to the contents of the vials when desired.
For more than sixty years injectable drugs have been packed in glass vials. Such vials typically are formed of glass and have a cylindrical neck terminating in a flanged top or lip, with the opening to the interior of the vial extending through the neck. The neck is sealed by means of a rubber stopper and an aluminum seal or ferrule. When these types of vials are used in lyophilization (freeze drying) the vial is filled with liquid and then the stopper (which is a complex or complicated elastomeric member) is inserted part way into the vial so that the product can be lyophilized. In this regard, the standard stopper and vial combination often rely on a feature called a “blowback” on the inside of the vial's lip to mate with an indentation on the elastomeric stopper. This action keeps the stoppers from rising up during processing. Once the lyophilization process has occurred the stopper is then fully seated in place, e.g., pushed down, so that it is completely within the neck of the vial during the final stages of the process and a ferrule applied to lock the stopper in place to thereby permanently seal the vial. Needless to say this is a complex operation and requires that the entire operation be accomplished within sterile conditions, e.g., within the freeze drying apparatus. Moreover, the construction of the closures require the use of vials having the blowback feature, thereby limiting the materials that can be used to form the vials to glass, e.g., plastic materials have not proved economically viable for producing vials with a viable blowback feature.
In U.S. Pat. No. 8,544,665 (Bogle et al.), which is assigned to the same assignee as this invention and whose disclosure is specifically incorporated by reference herein, there is disclosed and claimed a cap system for permanently sealing a pharmaceutical vial which overcomes the disadvantages of the prior art. That cap system basically comprises an elastomeric stopper, a retainer member and a locking cap member. The cap system of that patent application is particularly to be used on a conventional glass pharmaceutical vial having an interior, an opening to the interior of the vial and a flanged neck surrounding the opening, the flanged neck having an undersurface. The elastomeric stopper of the cap system has a body portion. The retainer member has a top wall and a peripheral sidewall. A plurality of resilient fingers is located about the periphery of the sidewall. The locking cap member comprises a peripheral sidewall including inwardly projecting members and is slidably coupled to the retainer member. The stopper is arranged to be secured to the vial so that its body portion partially closes the opening of the vial. The retainer member is arranged to be secured to the vial with its fingers being arranged to flex over the flanged neck of the vial and then snap into engagement with the undersurface of the flanged neck of the vial and with portions of the top wall of the retainer member in engagement with portions of the stopper to hold the stopper in place on the vial to seal the opening in the vial and prevent removal of said stopper from the vial. The locking cap member is arranged to be slidably secured over the retainer member after the retainer member has sealed the opening in the vial to lock it in a fixed position with respect to the retainer member, whereupon its inwardly projecting members apply an inward force on the fingers of the retainer member to ensure that the vial is permanently sealed.
While the cap system of the foregoing patent is eminently suitable for its intended purposes it nevertheless leaves something to be desired from the standpoint of facilitating access to the contents of the vial after the vial has been permanently sealed.
The subject invention addresses that need.
In accordance with one aspect of the invention there is provided a cap system for a pharmaceutical vial having an interior in which a flowable material is disposed, an opening to the interior of the vial and a flanged neck surrounding the opening, with the flanged neck having an undersurface. The cap system comprises an elastomeric stopper, a retainer member, a locking member, a cap member and a piercing member. The elastomeric stopper is arranged to be secured to the vial. The retainer member comprises a sidewall and a plurality of resilient fingers located about the periphery of the sidewall. The retainer member is arranged to be secured to the vial with the fingers of the retainer member being arranged to flex over the flanged neck of the vial and then snap into engagement with the undersurface of the flanged neck of the vial. The locking member is slidably coupled to the retainer member and comprises a peripheral sidewall including inwardly projecting members. The locking member is arranged slid to a fixed position with respect to the retainer member, whereupon the inwardly projecting members of the locking member apply an inward force on the fingers of the retainer member to permanently seal the vial. The cap member is coupled to the locking member and is a hollow member having a socket therein. The piercing member is releasably located in the socket and has a piercing tip.
In accordance with one preferred aspect of this invention the cap member is slidably coupled to the locking member to enable the cap member to be slid from a retracted position to an extended position wherein the piercing tip of the piercing member passes through the stopper into the interior of the vial.
In accordance with another preferred aspect of this invention the cap member comprises a portion of an assembly additionally comprising a band releasably secured to the cap member. The band is arranged to be removed from the assembly to enable the cap member to be slid from the retracted position to the extended position.
In accordance with another preferred aspect of this invention the socket includes an internally threaded portion and wherein the piercing member comprises an externally threaded portion screwed within the internally threaded portion of the socket. The cap member is arranged to be unscrewed from the piercing member after the cap member is in the extended position, whereupon the cap member can be removed from the vial leaving the piercing member in place extending into the interior of the vial.
Referring now to the various figures of the drawing wherein like reference characters refer to like parts, there is shown in
The capping system 20 of this invention is particularly suitable for use on pharmaceuticals vial, such as a glass vial used for injectable drugs, but owing to the construction of the closure assembly it can also be used on vials made of plastic. The vial 22 basically comprises a hollow body 22A in which a pharmaceutical or other drug or other product to be held in a sterile state is located. The entrance to the interior of the vial's body is provided via an opening extending through a neck of the vial. The top of the neck of the vial is in the form of a lip or flange, having a generally planar top surface and a somewhat undercut surface. Since the retainer member 26 is constructed in accordance with the teaching of the '665 patent the interior surface of the opening in the neck of the vial need not include a blow-back annular recess, as has characterized prior art vials. Thus, the capping system of this invention enables one to use simpler vials than existing prior art glass vials. In fact, the subject invention enables one to use vials made of plastics as well.
The resilient stopper 24 is best seen in
As best seen in
The retainer member 26 is also best seen in
The capping system 20 is arranged to be placed on the neck of a vial so that the top surface of the vial's neck abuts the inwardly projecting lugs 26E of the retainer member 26. In this position the distal end 24C of the plug portion of the stopper 26 is located within the opening of the vial and will be a slight gap or open interface between the outer surface of the distal end of the stopper and the inner surface of neck of the vial. The gap is in fluid communication with the slots between the fingers 26D and hence to the ambient atmosphere to enable the lyophilization of the pharmaceutical within the vial (as described in the '665 patent).
In order to close the interface and thus temporarily seal the vial, all that is required is to apply a downward force on the retainer member to cause its fingers 26D to flex outward to ride over the flanged lip of the neck of the vial, so that the top surface of the inwardly projecting lugs 26E snap into place to engage the undersurface of the neck of the vial. Moreover, the tabs 26F ride over and tightly engage contiguous portions of the lip of the vial. This action traps the retainer member 26 on the neck of the vial and slightly compresses, e.g., 20% compression, the peripheral flange of stopper 24 between the top wall of the retainer member and the top surface of the neck of the vial, whereupon the drug contents in the vial are sealed off from the ambient atmosphere.
The locking member 28 of this invention takes the place of the locking cap member 28 that is shown in FIGS. 12-18 of the '665 patent and is also used to permanently lock the closure assembly in place on the vial. In addition, the locking member 28 of this invention includes a portion (to be described shortly) which cooperates with the cap assembly 30 and the piercing member 32 to enable the piercing member to gain access to the contents of the vial after it has been permanently sealed when such is desired, e.g., when it is desired to withdraw all or a portion of the pharmaceutical from the vial into a syringe or other instrument.
It should be pointed out at this juncture that the entire capping system 20 can be preassembled so that the entire assembly can be placed on a vial to be sealed at one time (although the sealing steps are carried out sequentially as described in the '665 patent). Alternatively, the locking cap member 28, the cap assembly 30 and the piercing member 32 can be preassembled as a unit and that unit can be applied onto a vial that has already been temporarily sealed by the retainer member 26 and the stopper 24.
The locking member 28 is best seen in
As best seen in
As best seen in
An annular ridge 36 extends about the periphery of the sidewall 28A. The ridge serves as a means which cooperates with a correspondingly shaped groove or recess in the cap assembly to hold the cap assembly in place on the locking member 28.
The locking member 28 is disposed on the top of the retainer member 26 in the same manner that the locking member of the '665 patent so that a force can be applied to it to cause it to move down with respect to the vial to a temporary sealing position. At this point the stopper 24 will be compressed and locked in place onto the neck of the vial by the inwardly projecting lugs 26E engaging the undersurface of the lip of the vial as described earlier. In order to permanently seal the vial, all that is required is to apply a further downward force onto the locking cap 28 to cause it to move to the down position shown in
As mentioned above the capping system subject invention is arranged to provide ready access to the contents of the vial via the piercing member 32. To that end, the piercing member 32 is held in a retracted or up position with respect to the sealed vial by the heretofore identified cap assembly 30 until access to the contents of the vial is desired. The cap assembly is best seen in
The band 40 is removable (i.e., releasably secured to the cap 38) so that once the band is removed the cap 38 can be moved (e.g., pushed) from the up or retracted position shown in
As best seen in
As mentioned earlier the piercing member 32 is held within the cap by means of its threaded portion 32B being screwed into the socket 38A. When the cap 38 is moved downward to the extended position the flange 32C of the piercing member slides over the cam surfaces at the top of the tabs 34, whereupon the tabs flex outward to allow the periphery of the flange to pass thereover and into the undercut portions of the tabs, whereupon the tabs flex back to trap the flange between them and the upper surface of the ledge 28B with the teeth 28D of the ledge 28B being received within corresponding recesses 32D of the flange. This action holds the piercing member in place so that its hollow piercing tip extends into the interior of the vial to provide access to the vial's contents. Once that action has occurred it is necessary to remove the cap 38 from the system 20 to provide access to the hollow interior of the threaded portion 32B of the piercing member so that a syringe (not shown) or some other instrument, e.g., a catheter, (not shown) can be connected to the piercing member to withdraw the contents of the vial into that syringe or other instrument through the piercing member.
The removal of the cap is achieved by unscrewing it with respect to the piercing member. The disposition of the teeth 28D of the locking member within the recesses 32D in the flange prevent the rotation of the piercing member as the cap is unscrewed from the piercing member. Thus, the cap can be unscrewed from the piercing member, while the piercing member is held stationary with respect to the locking member and hence with its piercing tip within the interior of the vial.
The hollow interior of the piercing member at the portion 32B can be in the form of a luer fitting or some other conventional connector to enable a syringe or other instrument to be connected to the piercing member. As mentioned earlier the piercing tip is a hollow pointed member. Thus, after the syringe or other instrument has been connected to the piercing member and operated the flowable contents of the vial can flow (i.e., be withdrawn) into the open end of the piercing tip, through its hollow interior and into the interior of the threaded portion 32B from whence the contents can flow into the syringe or other instrument.
It should be pointed out at this juncture that the capping system of this invention can be used in the same ways as described in the prior application. In addition, since the capping system of this invention in and of itself provides a means for gaining access to the sealed vial's contents it offers additional advantages to the pharmaceutical and medical fields.
It should also be pointed out that the capping system subject invention can be used for liquid fills, as well as freeze dried applications, allowing the closed container to leave a sterile environment with proven seal integrity and be handled in a non-classified environment. It could be made available in various finish sizes and the piercing member could be designed to fit with a variety of devices for administration.
Without further elaboration the foregoing will so fully illustrate my invention that others may, by applying current or future knowledge, adopt the same for use under various conditions of service.
Number | Name | Date | Kind |
---|---|---|---|
3577701 | Bott et al. | May 1971 | A |
3964234 | Hurst | Jun 1976 | A |
3998032 | Koebbeman | Dec 1976 | A |
4219986 | Osterhaus | Sep 1980 | A |
4230231 | Burnett et al. | Oct 1980 | A |
4435942 | Zaltsman | Mar 1984 | A |
4511044 | Connor et al. | Apr 1985 | A |
4552278 | Romanauskas | Nov 1985 | A |
4614077 | Muto et al. | Sep 1986 | A |
5064083 | Alexander et al. | Nov 1991 | A |
5085332 | Gettig et al. | Feb 1992 | A |
5314084 | Folta et al. | May 1994 | A |
5429256 | Kestenbaum | Jul 1995 | A |
5718348 | Manera | Feb 1998 | A |
5803284 | Grimard | Sep 1998 | A |
5819964 | Grimard | Oct 1998 | A |
6158196 | Trebbi et al. | Dec 2000 | A |
6478788 | Aneas | Nov 2002 | B1 |
6619499 | Lin | Sep 2003 | B1 |
6792743 | Odell et al. | Sep 2004 | B2 |
6857250 | Taylor | Feb 2005 | B1 |
6874301 | Kitamoto | Apr 2005 | B2 |
7024837 | Takebe et al. | Apr 2006 | B2 |
7204151 | Kitamoto et al. | Apr 2007 | B2 |
7467482 | Yarborough et al. | Dec 2008 | B2 |
8353145 | Zanini et al. | Jan 2013 | B2 |
8544665 | Bogle et al. | Oct 2013 | B2 |
8656688 | Schonfelder et al. | Feb 2014 | B2 |
8726619 | Bogle et al. | May 2014 | B2 |
8789347 | Bogle et al. | Jul 2014 | B2 |
20050022479 | Kitamoto | Feb 2005 | A1 |
20050086830 | Zukor et al. | Apr 2005 | A1 |
20050257623 | Kitamoto et al. | Nov 2005 | A1 |
20060134354 | Walters et al. | Jun 2006 | A1 |
20060287638 | Aneas | Dec 2006 | A1 |
20070102393 | Colin et al. | May 2007 | A1 |
20070272648 | Hamamoto et al. | Nov 2007 | A1 |
20100089862 | Schmitt | Apr 2010 | A1 |
20100224632 | Aneas | Sep 2010 | A1 |
20110068106 | Zukor et al. | Mar 2011 | A1 |
20130205719 | Wensley et al. | Aug 2013 | A1 |
20130240476 | Aneas | Sep 2013 | A1 |
Number | Date | Country |
---|---|---|
0909719 | Apr 1999 | EP |
2174884 | Apr 2010 | EP |
Entry |
---|
International Search Report for PCT/US2012/030513 dated Jun. 27, 2012. |
International Search Report for PCT/US2013/058933 dated Dec. 20, 2013. |
Number | Date | Country | |
---|---|---|---|
20180036203 A1 | Feb 2018 | US |